Toggle Main Menu Toggle Search

Open Access padlockePrints

Serum thyroglobulin in the monitoring of differentiated thyroid cancer

Lookup NU author(s): Dr Petros Perros

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Patients with differentiated thyroid cancer (DTC) usually have an excellent prognosis. Following surgical and radioiodine treatment to remove the cancer cells and suppressive doses of levothyroxine, long-term follow-up, including measurement of serum thyroglobulin (Tg) using a sensitive assay is required to detect recurrence. To interpret Tg results clinicians need to know the corresponding serum TSH concentration, have an appreciation of the clearance of Tg from patient serum following various interventions and the limitations of its measurement. The limitations of Tg immunoassay are well described and include potential interference from TgAb. For the majority of patients with DTC who are TgAb-negative, Tg measurement remains the most useful method of follow-up. For the TgAb-positive minority, interference and the possibility of producing erroneous results is a concern. Some assays are less badly affected than others and laboratories are advised to choose their assays carefully. Laboratories have sought to identify interferences using measurement of TgAb, lack of concordance between RIAs and immunometric assays and recovery of added Tg. More recently LC-MSMS assays to quantify Tg have been developed. They are not currently as sensitive as Tg immunoassays and it is likely these assays will, like immunoassays, be limited by Tg heterogeneity and standardization issues, although initial evaluations indicate that they may have value in the clinical setting as a second line test in antibody-positive DTC patients in whom Tg is unmeasurable by immunoassay.


Publication metadata

Author(s): Evans C, Tennant S, Perros P

Publication type: Article

Publication status: Published

Journal: Scandinavian Journal of Clinical & Laboratory Investigation

Year: 2016

Volume: 76

Issue: sup245

Pages: S119-S123

Online publication date: 17/08/2016

Acceptance date: 09/03/2016

ISSN (print): 0036-5513

ISSN (electronic): 1502-7686

Publisher: Taylor & Francis

URL: http://dx.doi.org/10.1080/00365513.2016.1210339

DOI: 10.1080/00365513.2016.1210339


Altmetrics

Altmetrics provided by Altmetric


Share